A prospective, non-interventional study in female patients with moderate to severe active rheumatoid arthritis in France receiving filgotinib for 2 years (PARROTFISH)

05/04/2022
01/10/2024
EU PAS number:
EUPAS46020
Study
Ongoing
Documents
Study protocol
No information provided.
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.